bpc-157 human clinical trials evidence safety fda status The peptide the recovery world has been waiting on just cleared a big hurdle, sort of. 🫳🏼 On July 23–24, an advisory committee voted 8–6 to recommend adding to the FDA commitee votes 8-6 to

The peptide has shown a wide range of cytoprotective effects in studies, in some cases more pronounced than those of standard cytoprotective agents

The main consideration is ensuring adequate hydration and electrolytes, as fasting plus peptide use may increase demands on both

They are very effective for male fertility

ACA, given at doses of 25 and 50 mg/kg/day to the animal model, suppressed the IgE level and the infiltration of eosinophils in the lungs

The World Anti-Doping Agency (WADA) includes it under the category of S0 Non-approved Substances, which covers any pharmacological agent that has not been approved for human use by a regulatory authority